BIOTIME INC's gross profit margin for the third quarter of its fiscal year 2015 has significantly increased when compared to the same period a year ago. Even though sales increased, the net income has decreased, representing a decrease to the bottom line. BIOTIME INC is extremely liquid. Currently, the Quick Ratio is 3.13 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has increased from the same period last year.
During the same period, stockholders' equity ("net worth") has increased by 18.77% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q3 FY15||Q3 FY14|
|Net Sales ($mil)||2.31||1.18|
|Net Income ($mil)||-13.63||-8.29|
|Balance Sheet||Q3 FY15||Q3 FY14|
|Cash & Equiv. ($mil)||29.38||7.42|
|Total Assets ($mil)||76.86||55.66|
|Total Debt ($mil)||0.66||0.11|
|Profitability||Q3 FY15||Q3 FY14|
|Gross Profit Margin||-673.29||-888.82|
|Return on Assets||-57.42||-81.67|
|Return on Equity||-341.96||-414.26|
|Debt||Q3 FY15||Q3 FY14|
|Share Data||Q3 FY15||Q3 FY14|
|Shares outstanding (mil)||82.05||68.29|
|Div / share||0.0||0.0|
|Book value / share||0.16||0.16|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||312170.0||317877.0|
SELL. This stock’s P/E ratio is negative, making its value useless in the assessment of premium or discount valuation, only displaying that the company has negative earnings per share. For additional comparison, its price-to-book ratio of 20.77 indicates a significant premium versus the S&P 500 average of 2.77 and a significant premium versus the industry average of 16.75. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. After reviewing these and other key valuation criteria, BIOTIME INC proves to trade at a premium to investment alternatives within the industry.
|BTX NM||Peers 47.43||BTX NM||Peers 42.69|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
BTX's P/E is negative making this valuation measure meaningless.
Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
BTX's P/CF is negative making the measure meaningless.
|BTX NA||Peers 19.59||BTX NA||Peers 0.56|
Neutral. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth potential.
Ratio not available.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|BTX 20.77||Peers 16.75||BTX 24.00||Peers 14.89|
Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
BTX is trading at a premium to its peers.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
BTX is expected to have an earnings growth rate that significantly exceeds its peers.
|BTX 36.29||Peers 289.74||BTX 42.18||Peers 60.69|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
BTX is trading at a significant discount to its industry on this measurement.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
BTX significantly trails its peers on the basis of sales growth
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas